These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17085050)

  • 1. ErbB receptors: new insights on mechanisms and biology.
    Linggi B; Carpenter G
    Trends Cell Biol; 2006 Dec; 16(12):649-56. PubMed ID: 17085050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction.
    Lidke DS; Nagy P; Heintzmann R; Arndt-Jovin DJ; Post JN; Grecco HE; Jares-Erijman EA; Jovin TM
    Nat Biotechnol; 2004 Feb; 22(2):198-203. PubMed ID: 14704683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.
    Burgess AW; Cho HS; Eigenbrot C; Ferguson KM; Garrett TP; Leahy DJ; Lemmon MA; Sliwkowski MX; Ward CW; Yokoyama S
    Mol Cell; 2003 Sep; 12(3):541-52. PubMed ID: 14527402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ; Maihle NJ
    Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.
    Lenferink AE; Pinkas-Kramarski R; van de Poll ML; van Vugt MJ; Klapper LN; Tzahar E; Waterman H; Sela M; van Zoelen EJ; Yarden Y
    EMBO J; 1998 Jun; 17(12):3385-97. PubMed ID: 9628875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGF-ERBB signalling: towards the systems level.
    Citri A; Yarden Y
    Nat Rev Mol Cell Biol; 2006 Jul; 7(7):505-16. PubMed ID: 16829981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction and oncogenesis by ErbB/HER receptors.
    Marmor MD; Skaria KB; Yarden Y
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):903-13. PubMed ID: 14967450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut.
    Yusta B; Holland D; Koehler JA; Maziarz M; Estall JL; Higgins R; Drucker DJ
    Gastroenterology; 2009 Sep; 137(3):986-96. PubMed ID: 19523469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis.
    Gent J; van Kerkhof P; Roza M; Bu G; Strous GJ
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9858-63. PubMed ID: 12105275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced ErbB receptor dimerization.
    Lemmon MA
    Exp Cell Res; 2009 Feb; 315(4):638-48. PubMed ID: 19038249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between integrins and growth factor receptors in signaling and endocytosis.
    Ivaska J; Heino J
    Annu Rev Cell Dev Biol; 2011; 27():291-320. PubMed ID: 21663443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity within the EGF family/ErbB receptor family signaling network.
    Riese DJ; Stern DF
    Bioessays; 1998 Jan; 20(1):41-8. PubMed ID: 9504046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-induced expression of the acetylcholine receptor requires endocytosis of ErbB receptors.
    Yang XL; Huang YZ; Xiong WC; Mei L
    Mol Cell Neurosci; 2005 Feb; 28(2):335-46. PubMed ID: 15691714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB receptors in fetal endothelium--a potential linkage point for inflammation-associated neonatal disorders.
    Bueter W; Dammann O; Zscheppang K; Korenbaum E; Dammann CE
    Cytokine; 2006 Dec; 36(5-6):267-75. PubMed ID: 17379533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.
    Graus-Porta D; Beerli RR; Daly JM; Hynes NE
    EMBO J; 1997 Apr; 16(7):1647-55. PubMed ID: 9130710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of HER2 and its importance in breast cancer.
    Yarden Y
    Oncology; 2001; 61 Suppl 2():1-13. PubMed ID: 11694782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.